Recode TX
United States · $189.0M raised
- Business Model
- B2B
- Total Funding
- $189.0M
- Last Round
- $29.0M Venture RoundSep 2025
- Rounds
- 3
About
ReCode Therapeutics develops mRNA and gene correction therapeutics for genetically defined diseases including cystic fibrosis.
Summary
Recode TX is a Biotech company based in United States. It has raised $189.0M in total across 3 rounds, most recently a $29.0M Venture Round round in Sep 2025. Investors include Pfizer Ventures, EcoR1 Capital and OrbiMed.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...